Treatment of statin side effects
AssigneeMagral Limited
InventorAnthony William Linnane
Life of this patent
Estimating the term…
Loading patent…
AssigneeMagral Limited
InventorAnthony William Linnane
Estimating the term…
The present invention relates generally to treatment of muscle pain and/or fatigue and to methods for treatment of side effects of statin therapy. In particular, the invention relates to the use of certain substituted benzoquinones, eg Coenzymes Q, particularly Coenzyme Q10 (Q10), in therapy. The invention also relates to the use of Q10 in combinative therapy with other agents such as uridine, its biological precursors or salts, esters, tautomers or analogues thereof (“uridine related compounds”). The invention is also directed to compositions, uses and combination packs or kits related to the treatment methods. In a preferred aspect the invention relates to a method of treatment of one or more side effects of statin therapy comprising administering to a subject in need of such treatment an effective amount of uridine, one of its biological precursors or a salt, ester, tautomer or analogue thereof either simultaneously, sequentially or separately to administration of an effective amount of at least one compound of Formula (I).
A method of treatment of one or more side effects of statin therapy comprising administering to a subject in need of such treatment an effective amount of uridine, one of its biological precursors or a salt, ester, tautomer or analogue thereof either simultaneously, sequentially or separately to administration of an effective amount of at least one compound of Formula (I)
A method of treatment of one or more side effects of statin therapy comprising administering to a subject in need of such treatment an effective amount of magnesium orotate either simultaneously, sequentially or separately to administration of an effective amount of Coenzyme Q10, optionally in association with one of more pharmaceutically acceptable additives.
Use of uridine, one of its biological precursors or a salt, ester, tautomer or analogue thereof and at least one compound of Formula (I)
Use of magnesium orotate, Coenzyme Q10 and optionally one or more pharmaceutically acceptable additives in preparation of a medicament for treatment of one or more side effects of statin therapy.
A composition comprising uridine, one of its biological precursors or a salt, ester, tautomer or analogue thereof and at least one compound of Formula (I)
A composition comprising magnesium orotate, Coenzyme Q10 and optionally one or more pharmaceutically acceptable additives.
A combination pack or kit comprising uridine, one of its biological precursors or a salt, ester, tautomer or analogue thereof and at least one compound of Formula (I)
A combination pack or kit comprising at least one statin, uridine, one of its biological precursors or a salt, ester, tautomer or analogue thereof and at least one compound of Formula (I)
A combination pack or kit comprising at least one statin, magnesium orotate and Coenzyme Q10 wherein said pack or kit is adapted for the simultaneous, sequential or separate administration of the statin, magnesium orotate and Coenzyme Q10.
A method of treatment of muscle pain and/or fatigue comprising administering to a subject in need of such treatment an effective amount of at least one compound of Formula (I)
A method of treatment of a side effect of a drug therapy comprising administering to a subject in need of such treatment an effective amount of at least one compound of Formula (I)
Dependencies are inferred from the claim text.